Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR1530) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Tamsulosin
|
|||||
Synonyms |
Tamsolusin; Tamsulosin [INN:BAN]; Tamsulosina; Tamsulosina [INN-Spanish]; Tamsulosine; Tamsulosine [INN-French]; Tamsulosinum; Tamsulosinum [INN-Latin]; YM-617; Flomax; Flomax (TN); Flowmax; TAMSULOSIN; (-)-Tamsulosin; (R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide; 106133-20-4; 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide; 5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide; CHEBI:9398; CHEMBL836; G3P28OML5I; UNII-G3P28OML5I
|
|||||
Indication | Prostatic hyperplasia [ICD11: GA90] | Approved | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 408.5 | Topological Polar Surface Area | 108 | ||
Heavy Atom Count | 28 | Rotatable Bond Count | 11 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
Cross-matching ID |
|
|||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
References | ||||||
---|---|---|---|---|---|---|
1 | Tamsulosin was approved by FDA. The 2020 official website of the U.S. Food and Drug Administration. | |||||
2 | Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes. Xenobiotica. 1998 Oct;28(10):909-22. | |||||
3 | Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele | |||||
4 | Pharmacokinetics and plasma protein binding of tamsulosin hydrochloride in rats, dogs, and humans Drug Metab Dispos. 1998 Mar;26(3):240-5. | |||||
5 | Absorption, metabolism and excretion of tamsulosin hydrochloride in man Xenobiotica. 1996 Jun;26(6):637-45. doi: 10.3109/00498259609046739. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.